Recall Record

Fort Worth, TX, United States

CBI Laboratories, Inc. recalls

1 recall recorded since 2018, most recently on 10 December 2018. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0

Terminated Class III Drugs

Recall started
10 December 2018
Terminated
14 January 2020
Reason
Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
Distribution
United States, Maldives, Canada, United Arab Emirates, and New Zealand
Initiated
Voluntary: Firm initiated
Recall numbers
D-0341-2019, D-0342-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.